Shulou(Shulou.com)11/24 Report--

CTOnews.com, October 27, Capcom yesterday announced its results for the first half of fiscal year 2223 (April 1, 2022 to September 30, 2022). Net sales for the first half of the year were 49.067 billion yen, down 29.9% from the same period last year, and operating profit was 21.895 billion yen, down 24.3% from the same period a year earlier.

Coupled with the aggressive promotion of digital content sales strategy, Capcom sold 21.3 million games in the first half of the fiscal year, surpassing the previous fiscal year.

Capcom explained that the overall decline in revenue was due to fewer large new works than in the previous fiscal year, and Capcom intends to make up for the decline in revenue in the second half of the fiscal year, focusing on the sale of new works and the continued sale of old works. in order to achieve the company's goal of revenue growth for more than 10 years.

In addition, Capcom also announced sales of some games. "biochemical Evil 2: remaking" has sold more than 1000 million copies, bringing the total sales of the biochemical series to more than 131 million copies, making it Capcom's best-selling series of games.

Monster Hunter Rises: dawn sold more than 4.4 million copies in June, while Monster Hunter: rise has sold 1100 million copies, bringing the total sales of the Monster Hunter series to 8800 million. In addition, the "Street Fighter" series sold 4900 million copies and the "Ghost cry" series sold 2700 million copies.

CTOnews.com has learned that Capcom plans to launch "biochemical Evil 4: remake" on March 24, 2023, and the company expects to sell 4000 million copies in 2023.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.